FDA NEWS

FDA Approves Entereg to Help Restore Bowel Function Following Surgery
The U.S. Food and Drug Administration approved Entereg (alvimopan) today to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. Entereg will be used in hospitalized patients who can receive no more than 15 doses.

Drug to be Discontinued: Geocillin (carbenicillin indanyl sodium) tablets 382 mg
Pfizer has discontinued this product. There are no other FDA approved manufacturers currently for carbenicillin tablets.

Coronary Artery Plaque Imaging Device Cleared by FDA
The U.S. Food and Drug Administration has cleared for marketing a device that a doctor can use to see inside a blood vessel to assess the fat content of the plaque which builds up on the wall of the coronary arteries.

Current Drug Shortage: Neupro (rotigotine transdermal system)
UCB is preparing to recall all Neupro lots in the U.S. by May 2008

May 2008 Patient Safety News
Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.

Labels: FDA